linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Aster DM Healthcare Ltd.
 
Source DateBoard Meeting DateDetails
27 Apr 202630 Apr 2026 Audited Results
20 Mar 202626 Mar 2026 Interim Dividend
23 Jan 202630 Jan 2026 Employees Stock Option Plan & Quarterly Results
31 Oct 202506 Nov 2025 Employees Stock Option Plan & Quarterly Results
25 Jul 202530 Jul 2025 Quarterly Results
14 May 202520 May 2025 Final Dividend & Audited Results
27 Jan 202531 Jan 2025 Quarterly Results & Interim Dividend
27 Nov 202429 Nov 2024 Preferential Issue of shares Inter-alia, to consider the following: 1. To evaluate and approve the proposal for issuance of equity shares by way of preferential allotment of up to 5% paid-up capital of the Company (on post issue basis), in accordance with the provisions of the Companies Act, 2013, SEBI Regulations and such other applicable laws subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2. To consider conducting the postal ballot, to seek the approval of shareholders inter alia in respect of aforesaid proposal, if the same is approved by the Board.
17 Oct 202423 Oct 2024 Quarterly Results
25 Jul 202431 Jul 2024 Quarterly Results
23 May 202428 May 2024 Final Dividend & Quarterly Results
05 Apr 202412 Apr 2024 Interim Dividend & Special Dividend & Inter alia to: 1. consider declaration of interim dividend for the financial year 2023-24 2. consider declaration of special dividend on account of segregation of the GCC business through the sale by Affinity Holdings Pvt Ltd, a wholly owned material subsidiary of the Company of entities conducting business in the GCC region to Alpha GCC Holdings Limited.
02 Feb 202408 Feb 2024 Quarterly Results
07 Nov 202314 Nov 2023 Quarterly Results
08 Aug 202314 Aug 2023 Quarterly Results
19 May 202325 May 2023 Audited Results
08 Feb 202314 Feb 2023 Quarterly Results
03 Nov 202210 Nov 2022 Quarterly Results
05 Aug 202211 Aug 2022 Quarterly Results
16 May 202224 May 2022 Audited Results
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.